Amundi Roivant Sciences Ltd. Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Amundi holds 337,515 shares of ROIV stock, worth $3.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
337,515
Previous 293,496
15.0%
Holding current value
$3.43 Million
Previous $3.39 Million
17.9%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
330Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$668 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$630 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$485 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$447 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$359 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...